nodes	percent_of_prediction	percent_of_DWPC	metapath
Pantoprazole—ABCB1—kidney cancer	0.165	1	CbGaD
Pantoprazole—SLCO1B1—Pazopanib—kidney cancer	0.0498	0.092	CbGbCtD
Pantoprazole—ABCG2—Pazopanib—kidney cancer	0.0395	0.0731	CbGbCtD
Pantoprazole—ABCG2—Dactinomycin—kidney cancer	0.0362	0.0668	CbGbCtD
Pantoprazole—ABCG2—Erlotinib—kidney cancer	0.0282	0.0521	CbGbCtD
Pantoprazole—ABCB1—Temsirolimus—kidney cancer	0.0271	0.0502	CbGbCtD
Pantoprazole—ABCG2—Paclitaxel—kidney cancer	0.0258	0.0477	CbGbCtD
Pantoprazole—CYP3A4—Everolimus—kidney cancer	0.0241	0.0445	CbGbCtD
Pantoprazole—ABCG2—Sorafenib—kidney cancer	0.0229	0.0424	CbGbCtD
Pantoprazole—ABCG2—Vincristine—kidney cancer	0.0223	0.0412	CbGbCtD
Pantoprazole—ABCG2—Sunitinib—kidney cancer	0.0186	0.0344	CbGbCtD
Pantoprazole—CYP1A2—Pazopanib—kidney cancer	0.0163	0.0301	CbGbCtD
Pantoprazole—CYP3A4—Temsirolimus—kidney cancer	0.0163	0.0301	CbGbCtD
Pantoprazole—CYP2C9—Capecitabine—kidney cancer	0.0153	0.0283	CbGbCtD
Pantoprazole—ABCB1—Pazopanib—kidney cancer	0.0143	0.0264	CbGbCtD
Pantoprazole—ABCG2—Doxorubicin—kidney cancer	0.0139	0.0257	CbGbCtD
Pantoprazole—ABCB1—Dactinomycin—kidney cancer	0.013	0.0241	CbGbCtD
Pantoprazole—CYP1A2—Erlotinib—kidney cancer	0.0116	0.0215	CbGbCtD
Pantoprazole—ABCB1—Gemcitabine—kidney cancer	0.0103	0.0191	CbGbCtD
Pantoprazole—CYP2C19—Sorafenib—kidney cancer	0.0103	0.0189	CbGbCtD
Pantoprazole—ABCB1—Erlotinib—kidney cancer	0.0102	0.0188	CbGbCtD
Pantoprazole—CYP2C9—Paclitaxel—kidney cancer	0.00959	0.0177	CbGbCtD
Pantoprazole—CYP1A2—Sorafenib—kidney cancer	0.00946	0.0175	CbGbCtD
Pantoprazole—ABCB1—Paclitaxel—kidney cancer	0.00931	0.0172	CbGbCtD
Pantoprazole—CYP3A4—Pazopanib—kidney cancer	0.00854	0.0158	CbGbCtD
Pantoprazole—CYP2C9—Sorafenib—kidney cancer	0.00852	0.0158	CbGbCtD
Pantoprazole—ABCB1—Sorafenib—kidney cancer	0.00827	0.0153	CbGbCtD
Pantoprazole—ABCB1—Vinblastine—kidney cancer	0.00817	0.0151	CbGbCtD
Pantoprazole—ABCB1—Vincristine—kidney cancer	0.00803	0.0148	CbGbCtD
Pantoprazole—ABCB1—Sunitinib—kidney cancer	0.0067	0.0124	CbGbCtD
Pantoprazole—CYP3A4—Erlotinib—kidney cancer	0.00609	0.0113	CbGbCtD
Pantoprazole—CYP3A4—Paclitaxel—kidney cancer	0.00558	0.0103	CbGbCtD
Pantoprazole—ABCB1—Doxorubicin—kidney cancer	0.00502	0.00928	CbGbCtD
Pantoprazole—CYP3A4—Sorafenib—kidney cancer	0.00496	0.00916	CbGbCtD
Pantoprazole—CYP3A4—Vinblastine—kidney cancer	0.00489	0.00905	CbGbCtD
Pantoprazole—CYP3A4—Vincristine—kidney cancer	0.00481	0.00889	CbGbCtD
Pantoprazole—CYP3A4—Sunitinib—kidney cancer	0.00401	0.00742	CbGbCtD
Pantoprazole—CYP3A4—Doxorubicin—kidney cancer	0.00301	0.00556	CbGbCtD
Pantoprazole—CYP2C19—urine—kidney cancer	0.00184	0.154	CbGeAlD
Pantoprazole—CYP1A2—urine—kidney cancer	0.0015	0.125	CbGeAlD
Pantoprazole—CYP2C9—urine—kidney cancer	0.00143	0.119	CbGeAlD
Pantoprazole—ATP4A—renal system—kidney cancer	0.00129	0.108	CbGeAlD
Pantoprazole—ATP4A—kidney—kidney cancer	0.00125	0.104	CbGeAlD
Pantoprazole—CYP3A4—urine—kidney cancer	0.00109	0.0908	CbGeAlD
Pantoprazole—Rabeprazole—CYP1A1—kidney cancer	0.000755	0.295	CrCbGaD
Pantoprazole—SLCO1B1—renal system—kidney cancer	0.000692	0.0577	CbGeAlD
Pantoprazole—SLCO1B1—kidney—kidney cancer	0.000669	0.0557	CbGeAlD
Pantoprazole—Omeprazole—CYP1A1—kidney cancer	0.000616	0.24	CrCbGaD
Pantoprazole—Lansoprazole—CYP1A1—kidney cancer	0.000563	0.22	CrCbGaD
Pantoprazole—ABCG2—nephron tubule—kidney cancer	0.000421	0.0351	CbGeAlD
Pantoprazole—CYP1A2—renal system—kidney cancer	0.000368	0.0307	CbGeAlD
Pantoprazole—Omeprazole—ABCB1—kidney cancer	0.000327	0.128	CrCbGaD
Pantoprazole—Lansoprazole—ABCB1—kidney cancer	0.000299	0.117	CrCbGaD
Pantoprazole—CYP3A4—renal system—kidney cancer	0.000266	0.0222	CbGeAlD
Pantoprazole—CYP3A4—kidney—kidney cancer	0.000258	0.0215	CbGeAlD
Pantoprazole—ABCB1—nephron tubule—kidney cancer	0.000207	0.0173	CbGeAlD
Pantoprazole—ABCB1—renal system—kidney cancer	0.000189	0.0157	CbGeAlD
Pantoprazole—ABCB1—kidney—kidney cancer	0.000182	0.0152	CbGeAlD
Pantoprazole—ABCB1—cortex of kidney—kidney cancer	0.000178	0.0148	CbGeAlD
Pantoprazole—ABCB1—gonad—kidney cancer	0.000169	0.0141	CbGeAlD
Pantoprazole—Dry skin—Doxorubicin—kidney cancer	4.93e-05	0.000207	CcSEcCtD
Pantoprazole—Dysgeusia—Capecitabine—kidney cancer	4.92e-05	0.000207	CcSEcCtD
Pantoprazole—Dizziness—Sunitinib—kidney cancer	4.92e-05	0.000207	CcSEcCtD
Pantoprazole—Feeling abnormal—Gemcitabine—kidney cancer	4.92e-05	0.000207	CcSEcCtD
Pantoprazole—Shock—Paclitaxel—kidney cancer	4.91e-05	0.000207	CcSEcCtD
Pantoprazole—Vomiting—Sorafenib—kidney cancer	4.91e-05	0.000207	CcSEcCtD
Pantoprazole—Abdominal pain upper—Doxorubicin—kidney cancer	4.91e-05	0.000206	CcSEcCtD
Pantoprazole—Nervous system disorder—Paclitaxel—kidney cancer	4.9e-05	0.000206	CcSEcCtD
Pantoprazole—Thrombocytopenia—Paclitaxel—kidney cancer	4.89e-05	0.000206	CcSEcCtD
Pantoprazole—Tachycardia—Paclitaxel—kidney cancer	4.87e-05	0.000205	CcSEcCtD
Pantoprazole—Rash—Sorafenib—kidney cancer	4.87e-05	0.000205	CcSEcCtD
Pantoprazole—Dermatitis—Sorafenib—kidney cancer	4.87e-05	0.000205	CcSEcCtD
Pantoprazole—Back pain—Capecitabine—kidney cancer	4.86e-05	0.000204	CcSEcCtD
Pantoprazole—Breast disorder—Doxorubicin—kidney cancer	4.86e-05	0.000204	CcSEcCtD
Pantoprazole—Skin disorder—Paclitaxel—kidney cancer	4.85e-05	0.000204	CcSEcCtD
Pantoprazole—Toxic epidermal necrolysis—Doxorubicin—kidney cancer	4.84e-05	0.000203	CcSEcCtD
Pantoprazole—Aspartate aminotransferase increased—Doxorubicin—kidney cancer	4.84e-05	0.000203	CcSEcCtD
Pantoprazole—Headache—Sorafenib—kidney cancer	4.84e-05	0.000203	CcSEcCtD
Pantoprazole—Muscle spasms—Capecitabine—kidney cancer	4.83e-05	0.000203	CcSEcCtD
Pantoprazole—Hyperhidrosis—Paclitaxel—kidney cancer	4.83e-05	0.000203	CcSEcCtD
Pantoprazole—Diarrhoea—Dactinomycin—kidney cancer	4.81e-05	0.000202	CcSEcCtD
Pantoprazole—Nasopharyngitis—Doxorubicin—kidney cancer	4.81e-05	0.000202	CcSEcCtD
Pantoprazole—Anorexia—Paclitaxel—kidney cancer	4.76e-05	0.0002	CcSEcCtD
Pantoprazole—Gastritis—Doxorubicin—kidney cancer	4.76e-05	0.0002	CcSEcCtD
Pantoprazole—Alanine aminotransferase increased—Doxorubicin—kidney cancer	4.74e-05	0.000199	CcSEcCtD
Pantoprazole—Vision blurred—Capecitabine—kidney cancer	4.73e-05	0.000199	CcSEcCtD
Pantoprazole—Vomiting—Sunitinib—kidney cancer	4.73e-05	0.000199	CcSEcCtD
Pantoprazole—Body temperature increased—Gemcitabine—kidney cancer	4.72e-05	0.000198	CcSEcCtD
Pantoprazole—Tremor—Capecitabine—kidney cancer	4.7e-05	0.000198	CcSEcCtD
Pantoprazole—Rash—Sunitinib—kidney cancer	4.69e-05	0.000197	CcSEcCtD
Pantoprazole—Dermatitis—Sunitinib—kidney cancer	4.68e-05	0.000197	CcSEcCtD
Pantoprazole—Abdominal distension—Doxorubicin—kidney cancer	4.68e-05	0.000197	CcSEcCtD
Pantoprazole—Hypotension—Paclitaxel—kidney cancer	4.67e-05	0.000196	CcSEcCtD
Pantoprazole—Ill-defined disorder—Capecitabine—kidney cancer	4.66e-05	0.000196	CcSEcCtD
Pantoprazole—Headache—Sunitinib—kidney cancer	4.66e-05	0.000196	CcSEcCtD
Pantoprazole—Asthma—Doxorubicin—kidney cancer	4.65e-05	0.000195	CcSEcCtD
Pantoprazole—Influenza—Doxorubicin—kidney cancer	4.65e-05	0.000195	CcSEcCtD
Pantoprazole—Dysphagia—Doxorubicin—kidney cancer	4.65e-05	0.000195	CcSEcCtD
Pantoprazole—Anaemia—Capecitabine—kidney cancer	4.64e-05	0.000195	CcSEcCtD
Pantoprazole—Hypersensitivity—Vincristine—kidney cancer	4.63e-05	0.000195	CcSEcCtD
Pantoprazole—Eosinophilia—Doxorubicin—kidney cancer	4.6e-05	0.000193	CcSEcCtD
Pantoprazole—Nausea—Sorafenib—kidney cancer	4.59e-05	0.000193	CcSEcCtD
Pantoprazole—Pancreatitis—Doxorubicin—kidney cancer	4.55e-05	0.000191	CcSEcCtD
Pantoprazole—Musculoskeletal discomfort—Paclitaxel—kidney cancer	4.55e-05	0.000191	CcSEcCtD
Pantoprazole—Malaise—Capecitabine—kidney cancer	4.53e-05	0.00019	CcSEcCtD
Pantoprazole—Angina pectoris—Doxorubicin—kidney cancer	4.53e-05	0.00019	CcSEcCtD
Pantoprazole—Insomnia—Paclitaxel—kidney cancer	4.52e-05	0.00019	CcSEcCtD
Pantoprazole—Vertigo—Capecitabine—kidney cancer	4.51e-05	0.00019	CcSEcCtD
Pantoprazole—Asthenia—Vincristine—kidney cancer	4.51e-05	0.00019	CcSEcCtD
Pantoprazole—Syncope—Capecitabine—kidney cancer	4.5e-05	0.000189	CcSEcCtD
Pantoprazole—Leukopenia—Capecitabine—kidney cancer	4.49e-05	0.000189	CcSEcCtD
Pantoprazole—Paraesthesia—Paclitaxel—kidney cancer	4.48e-05	0.000189	CcSEcCtD
Pantoprazole—Vomiting—Dactinomycin—kidney cancer	4.47e-05	0.000188	CcSEcCtD
Pantoprazole—Bronchitis—Doxorubicin—kidney cancer	4.47e-05	0.000188	CcSEcCtD
Pantoprazole—Dyspnoea—Paclitaxel—kidney cancer	4.45e-05	0.000187	CcSEcCtD
Pantoprazole—Somnolence—Paclitaxel—kidney cancer	4.44e-05	0.000187	CcSEcCtD
Pantoprazole—Palpitations—Capecitabine—kidney cancer	4.44e-05	0.000187	CcSEcCtD
Pantoprazole—Rash—Dactinomycin—kidney cancer	4.44e-05	0.000187	CcSEcCtD
Pantoprazole—Nausea—Sunitinib—kidney cancer	4.42e-05	0.000186	CcSEcCtD
Pantoprazole—Loss of consciousness—Capecitabine—kidney cancer	4.41e-05	0.000186	CcSEcCtD
Pantoprazole—Pancytopenia—Doxorubicin—kidney cancer	4.41e-05	0.000185	CcSEcCtD
Pantoprazole—Dyspepsia—Paclitaxel—kidney cancer	4.4e-05	0.000185	CcSEcCtD
Pantoprazole—Cough—Capecitabine—kidney cancer	4.38e-05	0.000184	CcSEcCtD
Pantoprazole—Dysuria—Doxorubicin—kidney cancer	4.34e-05	0.000183	CcSEcCtD
Pantoprazole—Decreased appetite—Paclitaxel—kidney cancer	4.34e-05	0.000183	CcSEcCtD
Pantoprazole—Hypertension—Capecitabine—kidney cancer	4.34e-05	0.000182	CcSEcCtD
Pantoprazole—Upper respiratory tract infection—Doxorubicin—kidney cancer	4.32e-05	0.000182	CcSEcCtD
Pantoprazole—Gastrointestinal disorder—Paclitaxel—kidney cancer	4.31e-05	0.000181	CcSEcCtD
Pantoprazole—Fatigue—Paclitaxel—kidney cancer	4.31e-05	0.000181	CcSEcCtD
Pantoprazole—Diarrhoea—Vincristine—kidney cancer	4.3e-05	0.000181	CcSEcCtD
Pantoprazole—Pollakiuria—Doxorubicin—kidney cancer	4.29e-05	0.00018	CcSEcCtD
Pantoprazole—Asthenia—Gemcitabine—kidney cancer	4.28e-05	0.00018	CcSEcCtD
Pantoprazole—Myalgia—Capecitabine—kidney cancer	4.27e-05	0.00018	CcSEcCtD
Pantoprazole—Arthralgia—Capecitabine—kidney cancer	4.27e-05	0.00018	CcSEcCtD
Pantoprazole—Chest pain—Capecitabine—kidney cancer	4.27e-05	0.00018	CcSEcCtD
Pantoprazole—Pain—Paclitaxel—kidney cancer	4.27e-05	0.00018	CcSEcCtD
Pantoprazole—Constipation—Paclitaxel—kidney cancer	4.27e-05	0.00018	CcSEcCtD
Pantoprazole—Anxiety—Capecitabine—kidney cancer	4.26e-05	0.000179	CcSEcCtD
Pantoprazole—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—kidney cancer	4.25e-05	0.000179	CcSEcCtD
Pantoprazole—Photosensitivity reaction—Doxorubicin—kidney cancer	4.24e-05	0.000178	CcSEcCtD
Pantoprazole—Weight increased—Doxorubicin—kidney cancer	4.23e-05	0.000178	CcSEcCtD
Pantoprazole—Discomfort—Capecitabine—kidney cancer	4.22e-05	0.000178	CcSEcCtD
Pantoprazole—Pruritus—Gemcitabine—kidney cancer	4.22e-05	0.000177	CcSEcCtD
Pantoprazole—Weight decreased—Doxorubicin—kidney cancer	4.2e-05	0.000177	CcSEcCtD
Pantoprazole—Hyperglycaemia—Doxorubicin—kidney cancer	4.19e-05	0.000176	CcSEcCtD
Pantoprazole—Dry mouth—Capecitabine—kidney cancer	4.18e-05	0.000176	CcSEcCtD
Pantoprazole—Nausea—Dactinomycin—kidney cancer	4.18e-05	0.000176	CcSEcCtD
Pantoprazole—Pneumonia—Doxorubicin—kidney cancer	4.17e-05	0.000175	CcSEcCtD
Pantoprazole—Dizziness—Vincristine—kidney cancer	4.16e-05	0.000175	CcSEcCtD
Pantoprazole—Infestation NOS—Doxorubicin—kidney cancer	4.14e-05	0.000174	CcSEcCtD
Pantoprazole—Infestation—Doxorubicin—kidney cancer	4.14e-05	0.000174	CcSEcCtD
Pantoprazole—Confusional state—Capecitabine—kidney cancer	4.13e-05	0.000174	CcSEcCtD
Pantoprazole—Feeling abnormal—Paclitaxel—kidney cancer	4.12e-05	0.000173	CcSEcCtD
Pantoprazole—Stevens-Johnson syndrome—Doxorubicin—kidney cancer	4.11e-05	0.000173	CcSEcCtD
Pantoprazole—Oedema—Capecitabine—kidney cancer	4.1e-05	0.000172	CcSEcCtD
Pantoprazole—Gastrointestinal pain—Paclitaxel—kidney cancer	4.08e-05	0.000172	CcSEcCtD
Pantoprazole—Diarrhoea—Gemcitabine—kidney cancer	4.08e-05	0.000172	CcSEcCtD
Pantoprazole—Infection—Capecitabine—kidney cancer	4.07e-05	0.000171	CcSEcCtD
Pantoprazole—Neuropathy peripheral—Doxorubicin—kidney cancer	4.06e-05	0.000171	CcSEcCtD
Pantoprazole—Stomatitis—Doxorubicin—kidney cancer	4.04e-05	0.00017	CcSEcCtD
Pantoprazole—Jaundice—Doxorubicin—kidney cancer	4.04e-05	0.00017	CcSEcCtD
Pantoprazole—Shock—Capecitabine—kidney cancer	4.03e-05	0.00017	CcSEcCtD
Pantoprazole—Conjunctivitis—Doxorubicin—kidney cancer	4.03e-05	0.000169	CcSEcCtD
Pantoprazole—Urinary tract infection—Doxorubicin—kidney cancer	4.03e-05	0.000169	CcSEcCtD
Pantoprazole—Nervous system disorder—Capecitabine—kidney cancer	4.02e-05	0.000169	CcSEcCtD
Pantoprazole—Thrombocytopenia—Capecitabine—kidney cancer	4.01e-05	0.000169	CcSEcCtD
Pantoprazole—Tachycardia—Capecitabine—kidney cancer	4e-05	0.000168	CcSEcCtD
Pantoprazole—Vomiting—Vincristine—kidney cancer	4e-05	0.000168	CcSEcCtD
Pantoprazole—Skin disorder—Capecitabine—kidney cancer	3.98e-05	0.000167	CcSEcCtD
Pantoprazole—Sweating—Doxorubicin—kidney cancer	3.97e-05	0.000167	CcSEcCtD
Pantoprazole—Urticaria—Paclitaxel—kidney cancer	3.97e-05	0.000167	CcSEcCtD
Pantoprazole—Rash—Vincristine—kidney cancer	3.96e-05	0.000167	CcSEcCtD
Pantoprazole—Hyperhidrosis—Capecitabine—kidney cancer	3.96e-05	0.000167	CcSEcCtD
Pantoprazole—Dermatitis—Vincristine—kidney cancer	3.96e-05	0.000167	CcSEcCtD
Pantoprazole—Haematuria—Doxorubicin—kidney cancer	3.95e-05	0.000166	CcSEcCtD
Pantoprazole—Abdominal pain—Paclitaxel—kidney cancer	3.95e-05	0.000166	CcSEcCtD
Pantoprazole—Body temperature increased—Paclitaxel—kidney cancer	3.95e-05	0.000166	CcSEcCtD
Pantoprazole—Headache—Vincristine—kidney cancer	3.94e-05	0.000166	CcSEcCtD
Pantoprazole—Hepatobiliary disease—Doxorubicin—kidney cancer	3.92e-05	0.000165	CcSEcCtD
Pantoprazole—Epistaxis—Doxorubicin—kidney cancer	3.91e-05	0.000164	CcSEcCtD
Pantoprazole—Anorexia—Capecitabine—kidney cancer	3.91e-05	0.000164	CcSEcCtD
Pantoprazole—Sinusitis—Doxorubicin—kidney cancer	3.89e-05	0.000163	CcSEcCtD
Pantoprazole—Agranulocytosis—Doxorubicin—kidney cancer	3.87e-05	0.000163	CcSEcCtD
Pantoprazole—Hypotension—Capecitabine—kidney cancer	3.83e-05	0.000161	CcSEcCtD
Pantoprazole—Vomiting—Gemcitabine—kidney cancer	3.79e-05	0.000159	CcSEcCtD
Pantoprazole—Rash—Gemcitabine—kidney cancer	3.76e-05	0.000158	CcSEcCtD
Pantoprazole—Dermatitis—Gemcitabine—kidney cancer	3.76e-05	0.000158	CcSEcCtD
Pantoprazole—Haemoglobin—Doxorubicin—kidney cancer	3.74e-05	0.000157	CcSEcCtD
Pantoprazole—Headache—Gemcitabine—kidney cancer	3.74e-05	0.000157	CcSEcCtD
Pantoprazole—Nausea—Vincristine—kidney cancer	3.73e-05	0.000157	CcSEcCtD
Pantoprazole—Musculoskeletal discomfort—Capecitabine—kidney cancer	3.73e-05	0.000157	CcSEcCtD
Pantoprazole—Rhinitis—Doxorubicin—kidney cancer	3.73e-05	0.000157	CcSEcCtD
Pantoprazole—Hepatitis—Doxorubicin—kidney cancer	3.72e-05	0.000156	CcSEcCtD
Pantoprazole—Haemorrhage—Doxorubicin—kidney cancer	3.72e-05	0.000156	CcSEcCtD
Pantoprazole—Insomnia—Capecitabine—kidney cancer	3.71e-05	0.000156	CcSEcCtD
Pantoprazole—Hypoaesthesia—Doxorubicin—kidney cancer	3.7e-05	0.000156	CcSEcCtD
Pantoprazole—Pharyngitis—Doxorubicin—kidney cancer	3.69e-05	0.000155	CcSEcCtD
Pantoprazole—Paraesthesia—Capecitabine—kidney cancer	3.68e-05	0.000155	CcSEcCtD
Pantoprazole—Hypersensitivity—Paclitaxel—kidney cancer	3.68e-05	0.000155	CcSEcCtD
Pantoprazole—Urinary tract disorder—Doxorubicin—kidney cancer	3.67e-05	0.000154	CcSEcCtD
Pantoprazole—Oedema peripheral—Doxorubicin—kidney cancer	3.66e-05	0.000154	CcSEcCtD
Pantoprazole—Connective tissue disorder—Doxorubicin—kidney cancer	3.65e-05	0.000154	CcSEcCtD
Pantoprazole—Dyspnoea—Capecitabine—kidney cancer	3.65e-05	0.000154	CcSEcCtD
Pantoprazole—Urethral disorder—Doxorubicin—kidney cancer	3.64e-05	0.000153	CcSEcCtD
Pantoprazole—Dyspepsia—Capecitabine—kidney cancer	3.61e-05	0.000152	CcSEcCtD
Pantoprazole—Visual impairment—Doxorubicin—kidney cancer	3.58e-05	0.000151	CcSEcCtD
Pantoprazole—Asthenia—Paclitaxel—kidney cancer	3.58e-05	0.000151	CcSEcCtD
Pantoprazole—Decreased appetite—Capecitabine—kidney cancer	3.56e-05	0.00015	CcSEcCtD
Pantoprazole—Nausea—Gemcitabine—kidney cancer	3.54e-05	0.000149	CcSEcCtD
Pantoprazole—Gastrointestinal disorder—Capecitabine—kidney cancer	3.54e-05	0.000149	CcSEcCtD
Pantoprazole—Fatigue—Capecitabine—kidney cancer	3.53e-05	0.000149	CcSEcCtD
Pantoprazole—Pruritus—Paclitaxel—kidney cancer	3.53e-05	0.000149	CcSEcCtD
Pantoprazole—Erythema multiforme—Doxorubicin—kidney cancer	3.52e-05	0.000148	CcSEcCtD
Pantoprazole—Pain—Capecitabine—kidney cancer	3.5e-05	0.000147	CcSEcCtD
Pantoprazole—Constipation—Capecitabine—kidney cancer	3.5e-05	0.000147	CcSEcCtD
Pantoprazole—Eye disorder—Doxorubicin—kidney cancer	3.47e-05	0.000146	CcSEcCtD
Pantoprazole—Tinnitus—Doxorubicin—kidney cancer	3.47e-05	0.000146	CcSEcCtD
Pantoprazole—Flushing—Doxorubicin—kidney cancer	3.45e-05	0.000145	CcSEcCtD
Pantoprazole—Diarrhoea—Paclitaxel—kidney cancer	3.42e-05	0.000144	CcSEcCtD
Pantoprazole—Feeling abnormal—Capecitabine—kidney cancer	3.38e-05	0.000142	CcSEcCtD
Pantoprazole—Immune system disorder—Doxorubicin—kidney cancer	3.36e-05	0.000141	CcSEcCtD
Pantoprazole—Gastrointestinal pain—Capecitabine—kidney cancer	3.35e-05	0.000141	CcSEcCtD
Pantoprazole—Chills—Doxorubicin—kidney cancer	3.34e-05	0.00014	CcSEcCtD
Pantoprazole—Arrhythmia—Doxorubicin—kidney cancer	3.32e-05	0.00014	CcSEcCtD
Pantoprazole—Dizziness—Paclitaxel—kidney cancer	3.3e-05	0.000139	CcSEcCtD
Pantoprazole—Alopecia—Doxorubicin—kidney cancer	3.29e-05	0.000138	CcSEcCtD
Pantoprazole—Mental disorder—Doxorubicin—kidney cancer	3.26e-05	0.000137	CcSEcCtD
Pantoprazole—Urticaria—Capecitabine—kidney cancer	3.26e-05	0.000137	CcSEcCtD
Pantoprazole—Abdominal pain—Capecitabine—kidney cancer	3.24e-05	0.000136	CcSEcCtD
Pantoprazole—Body temperature increased—Capecitabine—kidney cancer	3.24e-05	0.000136	CcSEcCtD
Pantoprazole—Malnutrition—Doxorubicin—kidney cancer	3.24e-05	0.000136	CcSEcCtD
Pantoprazole—Flatulence—Doxorubicin—kidney cancer	3.19e-05	0.000134	CcSEcCtD
Pantoprazole—Tension—Doxorubicin—kidney cancer	3.18e-05	0.000134	CcSEcCtD
Pantoprazole—Vomiting—Paclitaxel—kidney cancer	3.18e-05	0.000133	CcSEcCtD
Pantoprazole—Dysgeusia—Doxorubicin—kidney cancer	3.17e-05	0.000133	CcSEcCtD
Pantoprazole—Rash—Paclitaxel—kidney cancer	3.15e-05	0.000132	CcSEcCtD
Pantoprazole—Dermatitis—Paclitaxel—kidney cancer	3.15e-05	0.000132	CcSEcCtD
Pantoprazole—Nervousness—Doxorubicin—kidney cancer	3.14e-05	0.000132	CcSEcCtD
Pantoprazole—Back pain—Doxorubicin—kidney cancer	3.13e-05	0.000132	CcSEcCtD
Pantoprazole—Headache—Paclitaxel—kidney cancer	3.13e-05	0.000132	CcSEcCtD
Pantoprazole—Muscle spasms—Doxorubicin—kidney cancer	3.11e-05	0.000131	CcSEcCtD
Pantoprazole—Vision blurred—Doxorubicin—kidney cancer	3.05e-05	0.000128	CcSEcCtD
Pantoprazole—Hypersensitivity—Capecitabine—kidney cancer	3.02e-05	0.000127	CcSEcCtD
Pantoprazole—Ill-defined disorder—Doxorubicin—kidney cancer	3e-05	0.000126	CcSEcCtD
Pantoprazole—Anaemia—Doxorubicin—kidney cancer	2.99e-05	0.000126	CcSEcCtD
Pantoprazole—Agitation—Doxorubicin—kidney cancer	2.97e-05	0.000125	CcSEcCtD
Pantoprazole—Nausea—Paclitaxel—kidney cancer	2.97e-05	0.000125	CcSEcCtD
Pantoprazole—Asthenia—Capecitabine—kidney cancer	2.94e-05	0.000124	CcSEcCtD
Pantoprazole—Malaise—Doxorubicin—kidney cancer	2.92e-05	0.000123	CcSEcCtD
Pantoprazole—Vertigo—Doxorubicin—kidney cancer	2.91e-05	0.000122	CcSEcCtD
Pantoprazole—Syncope—Doxorubicin—kidney cancer	2.9e-05	0.000122	CcSEcCtD
Pantoprazole—Pruritus—Capecitabine—kidney cancer	2.9e-05	0.000122	CcSEcCtD
Pantoprazole—Leukopenia—Doxorubicin—kidney cancer	2.9e-05	0.000122	CcSEcCtD
Pantoprazole—Palpitations—Doxorubicin—kidney cancer	2.86e-05	0.00012	CcSEcCtD
Pantoprazole—Loss of consciousness—Doxorubicin—kidney cancer	2.84e-05	0.00012	CcSEcCtD
Pantoprazole—Cough—Doxorubicin—kidney cancer	2.82e-05	0.000119	CcSEcCtD
Pantoprazole—Convulsion—Doxorubicin—kidney cancer	2.8e-05	0.000118	CcSEcCtD
Pantoprazole—Diarrhoea—Capecitabine—kidney cancer	2.8e-05	0.000118	CcSEcCtD
Pantoprazole—Hypertension—Doxorubicin—kidney cancer	2.79e-05	0.000117	CcSEcCtD
Pantoprazole—Arthralgia—Doxorubicin—kidney cancer	2.76e-05	0.000116	CcSEcCtD
Pantoprazole—Chest pain—Doxorubicin—kidney cancer	2.76e-05	0.000116	CcSEcCtD
Pantoprazole—Myalgia—Doxorubicin—kidney cancer	2.76e-05	0.000116	CcSEcCtD
Pantoprazole—Anxiety—Doxorubicin—kidney cancer	2.75e-05	0.000115	CcSEcCtD
Pantoprazole—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—kidney cancer	2.74e-05	0.000115	CcSEcCtD
Pantoprazole—Discomfort—Doxorubicin—kidney cancer	2.72e-05	0.000114	CcSEcCtD
Pantoprazole—Dizziness—Capecitabine—kidney cancer	2.71e-05	0.000114	CcSEcCtD
Pantoprazole—Dry mouth—Doxorubicin—kidney cancer	2.7e-05	0.000113	CcSEcCtD
Pantoprazole—Confusional state—Doxorubicin—kidney cancer	2.66e-05	0.000112	CcSEcCtD
Pantoprazole—Anaphylactic shock—Doxorubicin—kidney cancer	2.64e-05	0.000111	CcSEcCtD
Pantoprazole—Oedema—Doxorubicin—kidney cancer	2.64e-05	0.000111	CcSEcCtD
Pantoprazole—Infection—Doxorubicin—kidney cancer	2.62e-05	0.00011	CcSEcCtD
Pantoprazole—Vomiting—Capecitabine—kidney cancer	2.61e-05	0.00011	CcSEcCtD
Pantoprazole—Shock—Doxorubicin—kidney cancer	2.6e-05	0.000109	CcSEcCtD
Pantoprazole—Nervous system disorder—Doxorubicin—kidney cancer	2.59e-05	0.000109	CcSEcCtD
Pantoprazole—Thrombocytopenia—Doxorubicin—kidney cancer	2.59e-05	0.000109	CcSEcCtD
Pantoprazole—Rash—Capecitabine—kidney cancer	2.58e-05	0.000109	CcSEcCtD
Pantoprazole—Dermatitis—Capecitabine—kidney cancer	2.58e-05	0.000109	CcSEcCtD
Pantoprazole—Tachycardia—Doxorubicin—kidney cancer	2.58e-05	0.000108	CcSEcCtD
Pantoprazole—Headache—Capecitabine—kidney cancer	2.57e-05	0.000108	CcSEcCtD
Pantoprazole—Skin disorder—Doxorubicin—kidney cancer	2.57e-05	0.000108	CcSEcCtD
Pantoprazole—Hyperhidrosis—Doxorubicin—kidney cancer	2.55e-05	0.000107	CcSEcCtD
Pantoprazole—Anorexia—Doxorubicin—kidney cancer	2.52e-05	0.000106	CcSEcCtD
Pantoprazole—Hypotension—Doxorubicin—kidney cancer	2.47e-05	0.000104	CcSEcCtD
Pantoprazole—Nausea—Capecitabine—kidney cancer	2.43e-05	0.000102	CcSEcCtD
Pantoprazole—Musculoskeletal discomfort—Doxorubicin—kidney cancer	2.41e-05	0.000101	CcSEcCtD
Pantoprazole—Insomnia—Doxorubicin—kidney cancer	2.39e-05	0.0001	CcSEcCtD
Pantoprazole—Paraesthesia—Doxorubicin—kidney cancer	2.37e-05	9.97e-05	CcSEcCtD
Pantoprazole—Dyspnoea—Doxorubicin—kidney cancer	2.36e-05	9.9e-05	CcSEcCtD
Pantoprazole—Somnolence—Doxorubicin—kidney cancer	2.35e-05	9.87e-05	CcSEcCtD
Pantoprazole—Dyspepsia—Doxorubicin—kidney cancer	2.33e-05	9.78e-05	CcSEcCtD
Pantoprazole—Decreased appetite—Doxorubicin—kidney cancer	2.3e-05	9.66e-05	CcSEcCtD
Pantoprazole—Gastrointestinal disorder—Doxorubicin—kidney cancer	2.28e-05	9.59e-05	CcSEcCtD
Pantoprazole—Fatigue—Doxorubicin—kidney cancer	2.28e-05	9.58e-05	CcSEcCtD
Pantoprazole—Pain—Doxorubicin—kidney cancer	2.26e-05	9.5e-05	CcSEcCtD
Pantoprazole—Constipation—Doxorubicin—kidney cancer	2.26e-05	9.5e-05	CcSEcCtD
Pantoprazole—Feeling abnormal—Doxorubicin—kidney cancer	2.18e-05	9.15e-05	CcSEcCtD
Pantoprazole—Gastrointestinal pain—Doxorubicin—kidney cancer	2.16e-05	9.08e-05	CcSEcCtD
Pantoprazole—Urticaria—Doxorubicin—kidney cancer	2.1e-05	8.82e-05	CcSEcCtD
Pantoprazole—Body temperature increased—Doxorubicin—kidney cancer	2.09e-05	8.78e-05	CcSEcCtD
Pantoprazole—Abdominal pain—Doxorubicin—kidney cancer	2.09e-05	8.78e-05	CcSEcCtD
Pantoprazole—Hypersensitivity—Doxorubicin—kidney cancer	1.95e-05	8.18e-05	CcSEcCtD
Pantoprazole—Asthenia—Doxorubicin—kidney cancer	1.9e-05	7.97e-05	CcSEcCtD
Pantoprazole—Pruritus—Doxorubicin—kidney cancer	1.87e-05	7.86e-05	CcSEcCtD
Pantoprazole—Diarrhoea—Doxorubicin—kidney cancer	1.81e-05	7.6e-05	CcSEcCtD
Pantoprazole—CYP3A4—Metapathway biotransformation—GSTM1—kidney cancer	1.78e-05	0.000428	CbGpPWpGaD
Pantoprazole—Dizziness—Doxorubicin—kidney cancer	1.75e-05	7.34e-05	CcSEcCtD
Pantoprazole—CYP2C19—Metabolism—GLIPR1—kidney cancer	1.74e-05	0.000417	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—PPAT—kidney cancer	1.74e-05	0.000417	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism—ITPR2—kidney cancer	1.72e-05	0.000414	CbGpPWpGaD
Pantoprazole—ABCG2—Metabolism—CRABP1—kidney cancer	1.72e-05	0.000412	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	1.71e-05	0.000412	CbGpPWpGaD
Pantoprazole—CYP3A4—Biological oxidations—CYP1A1—kidney cancer	1.71e-05	0.000411	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	1.7e-05	0.000407	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—PPAT—kidney cancer	1.69e-05	0.000407	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—GLIPR1—kidney cancer	1.69e-05	0.000407	CbGpPWpGaD
Pantoprazole—CYP3A4—Metapathway biotransformation—CYP1A1—kidney cancer	1.69e-05	0.000405	CbGpPWpGaD
Pantoprazole—Vomiting—Doxorubicin—kidney cancer	1.68e-05	7.06e-05	CcSEcCtD
Pantoprazole—Rash—Doxorubicin—kidney cancer	1.67e-05	7e-05	CcSEcCtD
Pantoprazole—Dermatitis—Doxorubicin—kidney cancer	1.66e-05	7e-05	CcSEcCtD
Pantoprazole—CYP1A2—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	1.66e-05	0.0004	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—PDHB—kidney cancer	1.66e-05	0.000398	CbGpPWpGaD
Pantoprazole—Headache—Doxorubicin—kidney cancer	1.65e-05	6.96e-05	CcSEcCtD
Pantoprazole—CYP1A2—Biological oxidations—POMC—kidney cancer	1.65e-05	0.000397	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	1.65e-05	0.000396	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—APRT—kidney cancer	1.61e-05	0.000387	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—FH—kidney cancer	1.61e-05	0.000387	CbGpPWpGaD
Pantoprazole—ABCG2—Metabolism—ITPR2—kidney cancer	1.6e-05	0.000383	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism of lipids and lipoproteins—POMC—kidney cancer	1.59e-05	0.000382	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—PPAT—kidney cancer	1.58e-05	0.00038	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—GLIPR1—kidney cancer	1.58e-05	0.00038	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	1.58e-05	0.000379	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—FH—kidney cancer	1.58e-05	0.000378	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—APRT—kidney cancer	1.58e-05	0.000378	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism—GSTT1—kidney cancer	1.57e-05	0.000377	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism—ACHE—kidney cancer	1.57e-05	0.000377	CbGpPWpGaD
Pantoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—kidney cancer	1.57e-05	0.000377	CbGpPWpGaD
Pantoprazole—Nausea—Doxorubicin—kidney cancer	1.57e-05	6.6e-05	CcSEcCtD
Pantoprazole—CYP2C9—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	1.56e-05	0.000375	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—CCBL1—kidney cancer	1.56e-05	0.000375	CbGpPWpGaD
Pantoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—kidney cancer	1.55e-05	0.000373	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	1.55e-05	0.000371	CbGpPWpGaD
Pantoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—kidney cancer	1.52e-05	0.000365	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—GPC3—kidney cancer	1.52e-05	0.000364	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—ACY1—kidney cancer	1.51e-05	0.000362	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism—SCARB1—kidney cancer	1.49e-05	0.000357	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—GPC3—kidney cancer	1.48e-05	0.000356	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—CA2—kidney cancer	1.48e-05	0.000354	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism—PTGS1—kidney cancer	1.47e-05	0.000354	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—FH—kidney cancer	1.47e-05	0.000353	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—APRT—kidney cancer	1.47e-05	0.000353	CbGpPWpGaD
Pantoprazole—ABCG2—Metabolism—GSTT1—kidney cancer	1.46e-05	0.00035	CbGpPWpGaD
Pantoprazole—ABCG2—Metabolism—ACHE—kidney cancer	1.46e-05	0.00035	CbGpPWpGaD
Pantoprazole—ABCB1—Transmembrane transport of small molecules—SLC5A5—kidney cancer	1.45e-05	0.000347	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism—PSMD7—kidney cancer	1.44e-05	0.000347	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—CA2—kidney cancer	1.44e-05	0.000346	CbGpPWpGaD
Pantoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—kidney cancer	1.44e-05	0.000346	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—ALAD—kidney cancer	1.44e-05	0.000345	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	1.44e-05	0.000345	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	1.41e-05	0.000339	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—ST3GAL2—kidney cancer	1.4e-05	0.000337	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—ALAD—kidney cancer	1.4e-05	0.000337	CbGpPWpGaD
Pantoprazole—ABCB1—Transmembrane transport of small molecules—SLC2A1—kidney cancer	1.4e-05	0.000335	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—GPC3—kidney cancer	1.38e-05	0.000332	CbGpPWpGaD
Pantoprazole—ABCG2—Metabolism—SCARB1—kidney cancer	1.38e-05	0.000331	CbGpPWpGaD
Pantoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—kidney cancer	1.37e-05	0.00033	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—ALDH1A1—kidney cancer	1.37e-05	0.000329	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—ST3GAL2—kidney cancer	1.37e-05	0.000329	CbGpPWpGaD
Pantoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—kidney cancer	1.37e-05	0.000329	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism—BCHE—kidney cancer	1.37e-05	0.000329	CbGpPWpGaD
Pantoprazole—ABCG2—Metabolism—PTGS1—kidney cancer	1.36e-05	0.000328	CbGpPWpGaD
Pantoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—kidney cancer	1.36e-05	0.000326	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism—SLC5A5—kidney cancer	1.35e-05	0.000325	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—GLIPR1—kidney cancer	1.35e-05	0.000325	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—PPAT—kidney cancer	1.35e-05	0.000325	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—CA2—kidney cancer	1.35e-05	0.000323	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—ALDH1A1—kidney cancer	1.34e-05	0.000322	CbGpPWpGaD
Pantoprazole—ABCG2—Metabolism—PSMD7—kidney cancer	1.34e-05	0.000321	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	1.34e-05	0.000321	CbGpPWpGaD
Pantoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—kidney cancer	1.33e-05	0.000318	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	1.32e-05	0.000317	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—SLC5A3—kidney cancer	1.32e-05	0.000316	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—PGK1—kidney cancer	1.32e-05	0.000316	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—ALAD—kidney cancer	1.31e-05	0.000315	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism—SLC2A1—kidney cancer	1.31e-05	0.000314	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—LDHB—kidney cancer	1.29e-05	0.00031	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—SLC5A3—kidney cancer	1.28e-05	0.000308	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—PGK1—kidney cancer	1.28e-05	0.000308	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—PDHB—kidney cancer	1.28e-05	0.000307	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—ST3GAL2—kidney cancer	1.28e-05	0.000307	CbGpPWpGaD
Pantoprazole—CYP3A4—Biological oxidations—POMC—kidney cancer	1.28e-05	0.000306	CbGpPWpGaD
Pantoprazole—ABCG2—Metabolism—BCHE—kidney cancer	1.27e-05	0.000304	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	1.27e-05	0.000304	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—LDHB—kidney cancer	1.26e-05	0.000302	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—APRT—kidney cancer	1.26e-05	0.000302	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—FH—kidney cancer	1.26e-05	0.000302	CbGpPWpGaD
Pantoprazole—ABCG2—Metabolism—SLC5A5—kidney cancer	1.25e-05	0.000301	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—ALDH1A1—kidney cancer	1.25e-05	0.0003	CbGpPWpGaD
Pantoprazole—SLCO1B1—Transmembrane transport of small molecules—RAF1—kidney cancer	1.25e-05	0.000299	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	1.23e-05	0.000295	CbGpPWpGaD
Pantoprazole—ABCG2—Metabolism—SLC2A1—kidney cancer	1.21e-05	0.00029	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—CCBL1—kidney cancer	1.2e-05	0.000289	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—PGK1—kidney cancer	1.2e-05	0.000288	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—SLC5A3—kidney cancer	1.2e-05	0.000288	CbGpPWpGaD
Pantoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—kidney cancer	1.2e-05	0.000287	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—GPC3—kidney cancer	1.18e-05	0.000284	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—LDHB—kidney cancer	1.18e-05	0.000282	CbGpPWpGaD
Pantoprazole—ABCG2—Transmembrane transport of small molecules—RAF1—kidney cancer	1.15e-05	0.000277	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—CA2—kidney cancer	1.15e-05	0.000276	CbGpPWpGaD
Pantoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—kidney cancer	1.13e-05	0.000272	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—ALAD—kidney cancer	1.12e-05	0.000269	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—CA9—kidney cancer	1.12e-05	0.000269	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	1.11e-05	0.000265	CbGpPWpGaD
Pantoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—kidney cancer	1.1e-05	0.000264	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—ST3GAL2—kidney cancer	1.09e-05	0.000263	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	1.09e-05	0.000262	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—CA9—kidney cancer	1.09e-05	0.000262	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism—GSTP1—kidney cancer	1.09e-05	0.000262	CbGpPWpGaD
Pantoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—kidney cancer	1.08e-05	0.000259	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—ALDH1A1—kidney cancer	1.07e-05	0.000257	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—GLIPR1—kidney cancer	1.04e-05	0.000251	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—PPAT—kidney cancer	1.04e-05	0.000251	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism—ABCB1—kidney cancer	1.03e-05	0.000248	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—PGK1—kidney cancer	1.03e-05	0.000246	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—SLC5A3—kidney cancer	1.03e-05	0.000246	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—CA9—kidney cancer	1.02e-05	0.000245	CbGpPWpGaD
Pantoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—kidney cancer	1.02e-05	0.000244	CbGpPWpGaD
Pantoprazole—ABCG2—Metabolism—GSTP1—kidney cancer	1.01e-05	0.000242	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—LDHB—kidney cancer	1.01e-05	0.000241	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism—GSTM1—kidney cancer	1e-05	0.00024	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	9.97e-06	0.000239	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—APRT—kidney cancer	9.7e-06	0.000233	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—FH—kidney cancer	9.7e-06	0.000233	CbGpPWpGaD
Pantoprazole—ABCG2—Metabolism—ABCB1—kidney cancer	9.55e-06	0.000229	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—CRABP1—kidney cancer	9.51e-06	0.000228	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism—CYP1A1—kidney cancer	9.49e-06	0.000228	CbGpPWpGaD
Pantoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—kidney cancer	9.35e-06	0.000224	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—CRABP1—kidney cancer	9.28e-06	0.000223	CbGpPWpGaD
Pantoprazole—ABCG2—Metabolism—GSTM1—kidney cancer	9.27e-06	0.000223	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—GPC3—kidney cancer	9.12e-06	0.000219	CbGpPWpGaD
Pantoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—kidney cancer	9.04e-06	0.000217	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—CA2—kidney cancer	8.88e-06	0.000213	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—ITPR2—kidney cancer	8.84e-06	0.000212	CbGpPWpGaD
Pantoprazole—ABCG2—Metabolism—CYP1A1—kidney cancer	8.79e-06	0.000211	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—CA9—kidney cancer	8.72e-06	0.000209	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—CRABP1—kidney cancer	8.67e-06	0.000208	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—ALAD—kidney cancer	8.65e-06	0.000208	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—ITPR2—kidney cancer	8.63e-06	0.000207	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	8.52e-06	0.000205	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—ST3GAL2—kidney cancer	8.44e-06	0.000203	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—ALDH1A1—kidney cancer	8.25e-06	0.000198	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism of lipids and lipoproteins—POMC—kidney cancer	8.15e-06	0.000196	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—ACHE—kidney cancer	8.06e-06	0.000194	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—GSTT1—kidney cancer	8.06e-06	0.000194	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—ITPR2—kidney cancer	8.06e-06	0.000194	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—PGK1—kidney cancer	7.91e-06	0.00019	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—SLC5A3—kidney cancer	7.91e-06	0.00019	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—GSTT1—kidney cancer	7.87e-06	0.000189	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—ACHE—kidney cancer	7.87e-06	0.000189	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	7.8e-06	0.000187	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—LDHB—kidney cancer	7.76e-06	0.000186	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—SCARB1—kidney cancer	7.63e-06	0.000183	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—PTGS1—kidney cancer	7.56e-06	0.000181	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—SCARB1—kidney cancer	7.45e-06	0.000179	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism of lipids and lipoproteins—POMC—kidney cancer	7.43e-06	0.000178	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—CRABP1—kidney cancer	7.41e-06	0.000178	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—PSMD7—kidney cancer	7.41e-06	0.000178	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—PTGS1—kidney cancer	7.37e-06	0.000177	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—ACHE—kidney cancer	7.35e-06	0.000177	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—GSTT1—kidney cancer	7.35e-06	0.000177	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—PSMD7—kidney cancer	7.23e-06	0.000174	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism—POMC—kidney cancer	7.08e-06	0.00017	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—BCHE—kidney cancer	7.02e-06	0.000169	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—SCARB1—kidney cancer	6.96e-06	0.000167	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—SLC5A5—kidney cancer	6.94e-06	0.000167	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—ITPR2—kidney cancer	6.89e-06	0.000165	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—PTGS1—kidney cancer	6.89e-06	0.000165	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—BCHE—kidney cancer	6.86e-06	0.000165	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—SLC5A5—kidney cancer	6.77e-06	0.000163	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—PSMD7—kidney cancer	6.76e-06	0.000162	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—CA9—kidney cancer	6.73e-06	0.000162	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—SLC2A1—kidney cancer	6.7e-06	0.000161	CbGpPWpGaD
Pantoprazole—ABCG2—Metabolism—POMC—kidney cancer	6.55e-06	0.000157	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—SLC2A1—kidney cancer	6.54e-06	0.000157	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	6.5e-06	0.000156	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—BCHE—kidney cancer	6.4e-06	0.000154	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism of lipids and lipoproteins—POMC—kidney cancer	6.35e-06	0.000152	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—SLC5A5—kidney cancer	6.33e-06	0.000152	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—GSTT1—kidney cancer	6.28e-06	0.000151	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—ACHE—kidney cancer	6.28e-06	0.000151	CbGpPWpGaD
Pantoprazole—ABCB1—Transmembrane transport of small molecules—RAF1—kidney cancer	6.24e-06	0.00015	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—SLC2A1—kidney cancer	6.11e-06	0.000147	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—SCARB1—kidney cancer	5.95e-06	0.000143	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	5.93e-06	0.000142	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—PTGS1—kidney cancer	5.89e-06	0.000141	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—PSMD7—kidney cancer	5.77e-06	0.000139	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—CRABP1—kidney cancer	5.72e-06	0.000137	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	5.67e-06	0.000136	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism—PTGS2—kidney cancer	5.65e-06	0.000136	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—GSTP1—kidney cancer	5.59e-06	0.000134	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—BCHE—kidney cancer	5.47e-06	0.000131	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—GSTP1—kidney cancer	5.46e-06	0.000131	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—SLC5A5—kidney cancer	5.41e-06	0.00013	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—ITPR2—kidney cancer	5.32e-06	0.000128	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—ABCB1—kidney cancer	5.29e-06	0.000127	CbGpPWpGaD
Pantoprazole—ABCG2—Metabolism—PTGS2—kidney cancer	5.23e-06	0.000126	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—SLC2A1—kidney cancer	5.22e-06	0.000125	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	5.17e-06	0.000124	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—GSTM1—kidney cancer	5.14e-06	0.000123	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—GSTP1—kidney cancer	5.1e-06	0.000122	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	5.07e-06	0.000122	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—GSTM1—kidney cancer	5.01e-06	0.00012	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism—PTEN—kidney cancer	4.92e-06	0.000118	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—CYP1A1—kidney cancer	4.87e-06	0.000117	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—ACHE—kidney cancer	4.85e-06	0.000116	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—GSTT1—kidney cancer	4.85e-06	0.000116	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—ABCB1—kidney cancer	4.82e-06	0.000116	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—CYP1A1—kidney cancer	4.75e-06	0.000114	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—GSTM1—kidney cancer	4.68e-06	0.000112	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—SCARB1—kidney cancer	4.59e-06	0.00011	CbGpPWpGaD
Pantoprazole—ABCG2—Metabolism—PTEN—kidney cancer	4.56e-06	0.000109	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—PTGS1—kidney cancer	4.54e-06	0.000109	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—PSMD7—kidney cancer	4.46e-06	0.000107	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—CYP1A1—kidney cancer	4.44e-06	0.000107	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	4.42e-06	0.000106	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—GSTP1—kidney cancer	4.35e-06	0.000105	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—BCHE—kidney cancer	4.22e-06	0.000101	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—SLC5A5—kidney cancer	4.17e-06	0.0001	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—ABCB1—kidney cancer	4.12e-06	9.9e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—SLC2A1—kidney cancer	4.03e-06	9.68e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—GSTM1—kidney cancer	4e-06	9.61e-05	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	4e-06	9.6e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—CYP1A1—kidney cancer	3.79e-06	9.11e-05	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	3.65e-06	8.76e-05	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—POMC—kidney cancer	3.63e-06	8.72e-05	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—POMC—kidney cancer	3.54e-06	8.51e-05	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism—PIK3CA—kidney cancer	3.47e-06	8.34e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—GSTP1—kidney cancer	3.36e-06	8.07e-05	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—POMC—kidney cancer	3.31e-06	7.95e-05	CbGpPWpGaD
Pantoprazole—ABCG2—Metabolism—PIK3CA—kidney cancer	3.22e-06	7.72e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—ABCB1—kidney cancer	3.18e-06	7.64e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	3.12e-06	7.48e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—GSTM1—kidney cancer	3.09e-06	7.42e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—CYP1A1—kidney cancer	2.93e-06	7.03e-05	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—PTGS2—kidney cancer	2.9e-06	6.95e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—POMC—kidney cancer	2.83e-06	6.79e-05	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—PTGS2—kidney cancer	2.83e-06	6.79e-05	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—PTGS2—kidney cancer	2.64e-06	6.34e-05	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—PTEN—kidney cancer	2.53e-06	6.06e-05	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—PTEN—kidney cancer	2.46e-06	5.92e-05	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—PTEN—kidney cancer	2.3e-06	5.53e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—PTGS2—kidney cancer	2.26e-06	5.42e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—POMC—kidney cancer	2.18e-06	5.24e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—PTEN—kidney cancer	1.97e-06	4.72e-05	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—PIK3CA—kidney cancer	1.78e-06	4.28e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—PTGS2—kidney cancer	1.74e-06	4.18e-05	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—PIK3CA—kidney cancer	1.74e-06	4.17e-05	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—PIK3CA—kidney cancer	1.62e-06	3.9e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—PTEN—kidney cancer	1.52e-06	3.65e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—PIK3CA—kidney cancer	1.39e-06	3.33e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—PIK3CA—kidney cancer	1.07e-06	2.57e-05	CbGpPWpGaD
